Mr Mrs Miss Ms Dr Other

Dr
Inge
Muellejans

European Patent Attorney

Edinburgh Office Glasgow Office

Chemistry

Telephone. +44(0) 131 220 7500
Mobile. +44(0) 786 719 8074
Email. [email protected]

Experience

Specialising in the field of chemistry, particularly medical devices, fibres, fabrics, personal care and cosmetics, Inge has over 20 years of experience in the patent profession both in-house and in private practice. She deals with all IP related topics, in particular drafting and prosecuting patent applications, EPO opposition and appeal proceedings, opinions on freedom-to-operate and validity as well as IP strategy and portfolio management.

Inge has extensive experience dealing with freedom-to-operate, infringement and validity opinions which she partly obtained during the 11 years she worked in-house for a leading specialty chemical company in Germany. She has a broad range of expertise handling oppositions and appeals at the EPO as well as drafting and prosecuting patent applications worldwide.

In addition, she has managed global patent portfolios both in private practice and in-house providing strategic advice to patent professionals, marketing and application technology leaders. She also advises on the German law for employee’s inventions.

Inge graduated at RWTH Aachen University in Germany and obtained a PhD in Chemistry at the DWI Aachen while working on projects for the German Federation of Industrial Research Associations (AIF).

After two years of running the search department of a leading personal healthcare company, Inge joined a specialty chemical company where she qualified as a European Patent Attorney. She moved to Scotland in 2012 to work in private practice, before joining the Edinburgh office of HGF in January 2016.

Qualifications

Patent Attorney

Europe


BSC

RWTH Aachen

MSC

RWTH Aachen

PHD

RWTH Aachen

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.